Institutional Ownership
Tevogen Bio Hldgs Inc
CUSIP 88165K200COM NEWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
27
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 24.4K | $110.3K |
| 2 | Morgan Stanley | 17.3K | $78.3K |
| 3 | Geode Capital Management, LLC | 15.7K | $71.1K |
| 4 | Deutsche Bank AG\ | 15.3K | $69.3K |
| 5 | Fmr LLC | 10.2K | $45.9K |
| 6 | Russell Investments Group, Ltd. | 5.8K | $26.2K |
| 7 | Ubs Group AG | 3.6K | $16.1K |
| 8 | Rhumbline Advisers | 1.0K | $4.5K |
| 9 | Tower Research Capital LLC (Trc) | 941 | $4.3K |
| 10 | Jpmorgan Chase & Co | 479 | $2.1K |